You are here

JYANT Technologies, Inc.

Company Information
Address 3393 Raes Creek Road
Marietta, GA, 30008


Information

DUNS: 832442771

# of Employees: 5


Ownership Information

HUBZone Owned: N

Socially and Economically Disadvantaged: N

Woman Owned: N



Award Charts




Award Listing

  1. Anti CCL mAb to treat castration resistant prostate cancer

    Amount: $350,000.00

    Metastatic castration resistant prostate cancer CRPC PCa accounts for of PCa deaths and is associated with skeletal metastases CRPC affects patients differently making this disease difficult ...

    STTRPhase I2017Department of Health and Human Services National Institutes of Health
  2. Anti-CXCL13 mAb to mitigate prostate cancer health disparities

    Amount: $315,320.00

    DESCRIPTION provided by applicant The most common metastatic site for hormone refractory prostate cancer HRPC PCa is bone While docetaxel can prolong the overall survival in patients with metas ...

    STTRPhase I2015Department of Health and Human Services National Institutes of Health
  3. Novel adjuvant therapy for triple negative breast cancer

    Amount: $225,000.00

    DESCRIPTION provided by applicant Triple negative breast cancer TNBC is very difficult to treat and has no specific targeted therapies Chemotherapies used to treat this disease have many undesir ...

    STTRPhase I2015Department of Health and Human Services National Institutes of Health
  4. Interventions for Mild Traumatic Brain Injury

    Amount: $294,331.00

    DESCRIPTION (provided by applicant): There is a great need for new therapies for Crohn's disease (CD), which is a chronic, relapsing and tissue destructive inflammatory bowel disease (IBD). Estim ...

    SBIRPhase I2013Department of Health and Human Services
US Flag An Official Website of the United States Government